InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the full record of transactions filed by O'Brien Stephanie Monaghan, Director. Officer active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Aggregated, 7 disclosures have been logged. Activity tracked since 1 January 2022. The latest transaction was filed on 6 April 2026 (J). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to O'Brien Stephanie Monaghan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
25,666 sharesCommon StockSEC:0001193125-26-224592:0
5,750 shares0Common StockSEC:0001492422-26-000099:0
7,961 shares0Common StockSEC:0001492422-26-000011:0
6,267 shares0Common StockSEC:0001127602-25-000440:0
3,341 shares0Common StockSEC:0001127602-24-000118:0
3,867 shares0Common StockSEC:0000899243-23-000672:0
4,230 shares0Common StockSEC:0001127602-22-000497:0
7 of 7 declarations
About O'Brien Stephanie Monaghan
Stephanie Monaghan O'Brien is a Director at Apellis Pharmaceuticals, Inc. She brings expertise in management and business strategy to the board. Her role is essential in guiding strategic decisions and ensuring the sustainable growth of the company.
